KAT2A and renal cell carcinoma: We confirmed these findings via immunohistochemistry (IHC) in the RCC tumor samples from our hospital, in which immunostaining scores of KAT2A was notably higher in the advanced tumor samples than low-grade tumors or normal tissues (Figure 1G).